SLN

#2242
Silence Therapeutics Plc American Depository Share
5.44
+1.30%
Secteur:
Base:
Devise de Profit:
Range quotidien
5.44
5.44
Range Annuel
1.97
7.78
Changement quotidien
+1.30%
Changement Mensuel
+5.84%
Evolution sur 6 mois
+4.02%
Changement Annuel
+15.74%
Clôture Précédente
5.37
Open
5.44
Bid
Ask
Low
5.44
High
5.44
Volume
6
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 770.86 M
  • Employee 116
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.85
Price to sales ratio
22.07
Dividends per share
—
Dividend yield %
—

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Nouvelles